CHEK2 and breast cancer: Firstly, risk effects conferred by CHEK2 and 77 common variants acted multiplicatively [16] and more recently, two studies including variant status, individual clinical variables and PRS showed meaningful shifts in LTBCR in CHEK2 carriers regardless of a family history of BC [24,25].